Cellebrite DI Overview
Valuation check: CLBT's P/E ratio is 50.93, above the Technology sector average of 27.19.
Get informed when a big investor buys or sells
+ Follow50.93
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for CLBT is 50.93. That is above the Technology sector average of 27.19. Investors often review this figure alongside Cellebrite DI's historical trend and sector peers before judging valuation or financial health.
Against Technology companies, CLBT currently prints 50.93 for P/E ratio, while the sector average sits near 27.19. That is roughly 87.3% above the sector mean. Large gaps often invite a closer look at Cellebrite DI's growth, margins, and balance sheet.
A P/E ratio of 50.93 for Cellebrite DI is not 'good' or 'bad' on its own. Compare it with the peer average (27.19) and with CLBT's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting CLBT's P/E ratio (50.93), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Cellebrite DI's P/E ratio against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.
